InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The firm operates in multiple industry segments providing in-vitro (non-animal) consumer, product, and environmental safety test method to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. The company sells three proprietary in vitro products: Ocular Irritection used to evaluate the potential for ocular irritation, Irritection Dermal used to evaluate the potential for dermal irritation, and Corrositex used to determine corrosivity level classifications. The company sells its products to independent distributors, contract laboratories, and end users.
Follow-Up Questions
What is Invitro International (IVRO)'s P/E Ratio?
The P/E ratio of Invitro International is 236.0141
Who is the CEO of Invitro International?
W. Richard Ulmer is the President of Invitro International, joining the firm since 1994.
What is the price performance of IVRO stock?
The current price of IVRO is $0.075, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Invitro International?
Invitro International belongs to N/A industry and the sector is N/A
What is Invitro International market cap?
Invitro International's current market cap is $1.7M
